How Long Can a Cat Live with Diabetes?

Most cats diagnosed with diabetes live at least one to three years after diagnosis, and many live considerably longer with consistent treatment. A large study of nearly 500 diabetic cats found that about two-thirds survived more than a year, a quarter survived past three years, and roughly one in ten made it beyond five years.¹ Those numbers reflect a wide range of treatment approaches and owner circumstances, which means the outlook for any individual cat depends heavily on how the disease is managed and what else is going on in the cat’s body.

What the Survival Numbers Look Like

The most detailed survival data available comes from a study that followed 477 diabetic cats through owner questionnaires. Among cats that survived the first four weeks after diagnosis, the median survival time was about one year for those that had already died by the time the study collected data, and about two years for cats still alive at that point.¹ That “first four weeks” qualifier matters. The early period after diagnosis is the most dangerous, because owners and veterinarians are still dialing in insulin doses, the cat may be severely ill, and complications like ketoacidosis can develop before treatment stabilizes things.

The tail end of the survival curve is encouraging. About 10% of cats in the study lived more than five years after diagnosis, and a small number made it past eight years.¹ Since indoor cats in general often live into their mid-to-late teens, a cat diagnosed at age ten that survives five or more years with diabetes is reaching a fairly normal lifespan. The disease shortens life on average, but it does not have to be a death sentence.

The Euthanasia Problem

One reason the survival numbers look worse than the biology alone would predict is that a significant number of diabetic cats are euthanized not because the disease has become unmanageable but because owners feel overwhelmed. About 10% of cats are euthanized at the time of diagnosis, and another 10% are euthanized within the first twelve months of treatment.² That means roughly one in five diabetic cats never gets the chance to show how long they could have lived. The reasons are understandable: twice-daily injections, frequent vet visits, monitoring costs, and the stress of managing a chronic illness in an animal that may not cooperate. But it does mean that the published survival statistics include cats whose deaths were not caused by diabetes itself.

If you are reading this because your own cat was just diagnosed, that context matters. The survival data includes cats whose owners opted for euthanasia early on, cats with severe concurrent diseases, and cats that received minimal treatment. A cat that gets consistent, well-monitored care is likely to beat those averages.

Remission Is a Real Possibility

Unlike dogs, whose diabetes almost always requires lifelong insulin, cats have a genuine chance of going into remission, meaning their blood sugar returns to normal and they no longer need insulin at all. This happens because feline diabetes closely resembles type 2 diabetes in humans: it is driven by insulin resistance and a gradual loss of insulin-producing beta cells, and if you can break the cycle early enough, the pancreas can recover some function.

Remission rates vary widely depending on the treatment protocol. One study using twice-daily glargine insulin with home monitoring found that 47% of cats achieved remission.³ That is a striking number, though there is a catch: about 40% of cats that went into remission eventually relapsed, most within the first year.³ Still, even temporary remission gives the cat’s pancreas a break and often extends the period of good quality of life.

Several factors predict whether a cat will achieve remission. Younger cats at diagnosis had slightly better odds. Burmese cats were about five times more likely to enter remission than domestic shorthairs or medium-hairs. Cats that had received corticosteroids in the month before diagnosis, which can trigger a temporary form of diabetes, had roughly sevenfold greater odds of remission, presumably because the underlying beta-cell damage was less severe.³ Interestingly, the blood glucose level at the time of diagnosis did not predict remission, which runs counter to what many owners assume. A systematic review of feline diabetic remission concluded that no single factor reliably identifies which cats will achieve it, but that reversing glucose toxicity in the pancreas appears to be a central mechanism.⁴

Why the Type of Insulin Matters

Not all insulin types perform equally in cats. A study comparing glargine, protamine zinc (PZI), and lente insulin in newly diagnosed diabetic cats found that glargine-treated cats achieved better blood sugar control and had higher remission rates. All eight cats in the glargine group entered remission, compared to three in the PZI group and two in the lente group.⁵ The sample size was small (24 cats total), so those remission numbers should not be taken as universal rates. But the direction of the finding has been consistent across the literature: long-acting insulin analogs tend to produce better outcomes in cats.

For cats that do require lifelong insulin, the injection itself is usually less burdensome than owners expect. Insulin needles are extremely thin, and most cats tolerate injections well once a routine is established. The bigger ongoing challenge is monitoring, which we will get to shortly.

Diet as a Treatment Tool

Diet plays a surprisingly large role in managing feline diabetes, partly because the disease is so closely tied to obesity and carbohydrate metabolism. Cats are obligate carnivores with limited ability to handle high-carbohydrate diets, and many commercial dry cat foods are far higher in carbohydrates than a cat’s physiology is designed for.

A controlled study comparing a low-carbohydrate, low-fiber diet against a moderate-carbohydrate, high-fiber diet found that 68% of cats on the low-carbohydrate food reverted to a non-insulin-dependent state after 16 weeks, compared to 41% on the moderate-carbohydrate diet.⁶ That is a meaningful difference, and it helps explain why most veterinary diabetes specialists now recommend switching diabetic cats to a high-protein, low-carbohydrate wet food. For overweight cats, the initial insulin dose should be based on an estimate of the cat’s ideal body weight rather than its current weight, to reduce the risk of dangerous blood sugar drops.⁷

Newer Oral Treatments

Until recently, if your cat had diabetes, insulin injections were essentially the only effective option. Older oral drugs like glipizide, a sulfonylurea that stimulates the pancreas to release more insulin, worked in some cats but had significant limitations. Early trials found that it improved symptoms in roughly a third to half of cats that still had residual beta-cell function, but a longer study showed that 56% of cats eventually failed on glipizide and had to be switched to insulin.⁸ Side effects included vomiting, loss of appetite, and liver enzyme elevations. Perhaps worse, there was concern that by pushing the pancreas to produce more insulin (and more amyloid-forming protein along with it), glipizide could actually accelerate beta-cell destruction over time.⁹

The landscape changed with the approval of SGLT2 inhibitors for cats. These drugs, which include bexagliflozin and velagliflozin, work by blocking glucose reabsorption in the kidneys, causing excess sugar to be excreted in the urine. They do not require the pancreas to produce insulin at all, which makes the mechanism fundamentally different from older oral drugs. In the large clinical trial for velagliflozin (the SENSATION study), 81% of treated cats had blood glucose or fructosamine within normal ranges by day 180, and the vast majority showed improvement in excessive drinking and urination.¹⁰

These drugs are not without risk, however. The most serious complication is euglycemic diabetic ketoacidosis, a condition where dangerous ketone buildup occurs even though blood sugar readings look normal. In the SENSATION study, ketoacidosis developed in about 7% of cats, and most episodes happened within the first two weeks of treatment.¹⁰ SGLT2 inhibitors also require that the cat still has some functioning beta cells, so they are not suitable for every diabetic cat.¹¹ For owners who find insulin injections genuinely impossible, though, these once-daily liquid medications represent a real alternative that did not exist a few years ago.

Complications That Affect Survival

The complications of feline diabetes generally fall into two categories: acute crises that can be fatal quickly, and chronic problems that erode quality of life over time.

On the acute side, hypoglycemia from an insulin overdose is the complication owners fear most, and rightly so. A review of hypoglycemic episodes in diabetic cats found that the most common triggers were the cat not eating or vomiting after receiving insulin, or the owner accidentally giving a double dose.¹² Concurrent illnesses that change insulin requirements were also a common factor. Severe hypoglycemia can cause seizures, brain damage, or death if not caught quickly. The practical takeaway is that if your cat does not eat a meal, you should reduce or skip the insulin dose, and you should never guess at doses when you are unsure whether the last injection was given.

Diabetic neuropathy is the most visible chronic complication. Affected cats develop a distinctive flat-footed walk, placing their entire hind foot on the ground instead of walking on their toes. A study of seven cats with diabetes-associated neuropathy found hind-limb weakness, reduced reflexes, and slowed nerve conduction. Encouragingly, five of the seven cats saw their neurological signs improve after blood sugar was brought under control.¹³ If your cat is walking strangely on its back legs, that is often what is going on, and it is frequently reversible with good glycemic management.

Diseases That Complicate Diabetes

Several conditions can make feline diabetes harder to control and shorter-lived. Pancreatitis is the most common culprit. It frequently occurs alongside diabetes in cats, and the two diseases feed into each other: pancreatitis damages the organ that produces insulin, while poorly controlled diabetes may promote further pancreatic inflammation. Diagnosing pancreatitis in a diabetic cat is important because it commonly makes blood sugar regulation much more difficult.¹⁴

Acromegaly, a condition caused by a growth-hormone-secreting pituitary tumor, is another underdiagnosed cause of difficult diabetes. Research has shown that a significant proportion of cats whose diabetes is hard to control have underlying acromegaly driving their insulin resistance.¹⁵ These cats often need very high insulin doses and do not respond to standard treatment until the underlying tumor is addressed. If your cat’s insulin requirements keep climbing with no improvement in control, acromegaly is worth investigating.

How Monitoring Has Changed

One of the biggest shifts in feline diabetes management over the past decade is the rise of continuous glucose monitoring (CGM) and flash glucose monitoring devices originally designed for humans. These small sensors, attached to the cat’s skin (usually on the back or side of the neck), read interstitial glucose levels every few minutes and give owners a far more complete picture of blood sugar patterns than occasional spot checks at the vet’s office.

The FreeStyle Libre system has been evaluated specifically in diabetic cats and found to provide clinically useful estimates of blood glucose. The sensors were easy to place, well tolerated, and had good skin compatibility.¹⁶ Continuous monitoring also captures what happens at night, when owners are asleep and dangerous lows or persistent highs could otherwise go unnoticed.¹⁷

For owners who cannot use CGM, fructosamine blood tests remain a useful tool. Fructosamine reflects average blood sugar over the preceding two to three weeks, much like the HbA1c test in humans. A recent study found a strong correlation between fructosamine levels and average interstitial glucose readings, though there was meaningful overlap between categories, meaning fructosamine alone can sometimes be misleading about how well-controlled a cat truly is.¹⁸ In practice, many vets now recommend combining periodic fructosamine tests with at least some home glucose monitoring, whether by ear-prick checks or CGM sensors, to get the fullest picture.

What Is Actually Happening in the Pancreas

Understanding a little about why cats develop diabetes helps explain both the possibility of remission and the importance of early aggressive treatment. In most diabetic cats, the process starts with insulin resistance, often driven by obesity. The pancreas compensates by producing more insulin and more of a companion hormone called amyloid polypeptide (IAPP, also known as amylin). Over time, IAPP can form toxic amyloid deposits inside the insulin-producing islets, gradually destroying beta cells.⁹ Glucose toxicity compounds the damage: chronically high blood sugar itself further impairs beta-cell function and insulin secretion.¹⁹

This is why early and aggressive blood sugar control matters so much. If you can get glucose levels down quickly with insulin, you relieve the glucose toxicity and give surviving beta cells a chance to recover. Wait too long, and the amyloid damage may be irreversible. Interestingly, one pathology study found that while diabetic cats had about 65% less insulin-producing tissue than healthy cats, the amount of amyloid deposit was not significantly different between the two groups, suggesting that amyloid damage is common in aging cats generally and that other factors tip certain cats into clinical disease.²⁰ The picture that emerges is not one of a single clear cause but of multiple hits: obesity, amyloid buildup, glucose toxicity, and sometimes inflammation from pancreatitis all converging to overwhelm the pancreas.

This understanding also explains why treatments that force the pancreas to work harder, like the older drug glipizide, may actually be counterproductive in the long run. A study that induced diabetes in cats found that those treated with a drug that stimulated insulin (and IAPP) secretion developed significantly more amyloid deposits than cats treated with exogenous insulin, which kept IAPP secretion low.⁹ It is one of those cases where a treatment that looks effective in the short term may be doing damage under the surface.

1
PubMed Central. Survival, remission, and quality of life in diabetic cats
2
PubMed Central. Spectrum of veterinary care in feline diabetes mellitus
3
PubMed Central. Frequency of diabetic remission, predictors of remission and survival in cats using a low-cost, moderate-intensity, home-monitoring protocol and twice-daily glargine
4
The Veterinary Journal. Systematic review of feline diabetic remission: Separating fact from opinion
5
PubMed Central. Treatment of newly diagnosed diabetic cats with glargine insulin improves glycaemic control and results in higher probability of remission than protamine zinc and lente insulins
6
PubMed Central. Comparison of a low carbohydrate-low fiber diet and a moderate carbohydrate-high fiber diet in the management of feline diabetes mellitus
7
PubMed Central. Feline comorbidities: Pathophysiology and management of the obese diabetic cat
8
PubMed Central. Efficacy and Safety of Non-Insulin Antidiabetic Drugs in Cats: A Systematic Review
9
Molecular and Cellular Endocrinology. Pathogenesis of feline diabetes mellitus
10
PubMed. Velagliflozin, a once-daily, liquid, oral SGLT2 inhibitor, is effective as a stand-alone therapy for feline diabetes mellitus: the SENSATION study
11
PubMed Central. SGLT2 inhibitor use in the management of feline diabetes mellitus
12
PubMed Central. Hypoglycemic episodes in cats with diabetes mellitus: 30 cases (2013–2015)
13
PubMed. Neuropathy associated with diabetes mellitus in the cat
14
PubMed Central. Feline Comorbidities: Clinical perspective on diabetes mellitus and pancreatitis
15
PubMed Central. Feline acromegaly: an essential differential diagnosis for the difficult diabetic
16
PubMed Central. Evaluation of the FreeStyle Libre, a flash glucose monitoring system, in client-owned cats with diabetes mellitus
17
PubMed Central. Comparison of continuous glucose monitoring profiles during the day and night in healthy and diabetic cats
18
PubMed Central. Evaluating the correlation between serum fructosamine concentration and interstitial glucose concentration in cats with diabetes mellitus
19
PubMed Central. Current understanding of feline diabetes: part 1, pathogenesis
20
PubMed. Endocrine Pancreas in Cats With Diabetes Mellitus